Profile data is unavailable for this security.
About the company
BEIJING TIANTAN BIOLOGICAL PRODUCTS CORPORATION LIMITED is a China-based company principally engaged in the biopharmaceutical businesses. The Company’s primary products include preventive products, blood products and other biological products, such as the influenza A (H1N1) vaccines (split, inactivated),hepatitis B vaccines, poliomyelitis vaccines, measles-mump-rubella (MMR) vaccines, encephalitis B vaccines, influenza vaccinations, bacterial vaccines, human serum albumin (HSA) and intravenous immunoglobulin (IVIG), among others. The Company mainly distributes its products within domestic markets and to Hong Kong markets.
- Revenue in CNY (TTM)5.23bn
- Net income in CNY1.27bn
- Incorporated1998
- Employees4.86k
- LocationBeijing Tiantan Biological Products Corp LtdNo. 2Shuangqiao Road B, Chaoyang DistrictBEIJING 100024ChinaCHN
- Phone+86 1 065439720
- Fax+86 1 065436770
- Websitehttps://www.tiantanbio.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bluestar Adisseo Co | 14.95bn | 1.09bn | 30.25bn | 2.73k | 27.76 | 1.91 | -- | 2.02 | 0.4064 | 0.4064 | 5.57 | 5.90 | 0.6887 | 5.18 | 8.01 | 5,466,479.00 | 5.03 | 5.28 | 6.07 | 6.94 | 29.20 | 30.31 | 7.30 | 8.76 | 1.16 | 7.83 | 0.1105 | 21.81 | -9.26 | 2.92 | -95.82 | -43.75 | 2.74 | -19.09 |
| Kangmei Pharmaceutical Co Ltd | 5.21bn | 255.55m | 33.27bn | 4.41k | 129.59 | 4.73 | -- | 6.38 | 0.0185 | 0.0185 | 0.3766 | 0.5079 | 0.3626 | 1.45 | 2.55 | 1,182,457.00 | 1.80 | -17.60 | 2.77 | -32.24 | 20.63 | -72.78 | 4.95 | -101.19 | 0.8398 | -- | 0.0346 | -- | 16.60 | -22.17 | 103.81 | -22.83 | -53.51 | -- |
| Humanwell Healthcare Group Co Ltd | 25.56bn | 1.96bn | 38.85bn | 17.68k | 19.64 | 2.17 | -- | 1.52 | 1.21 | 1.21 | 15.87 | 10.95 | 0.6902 | 3.80 | 2.74 | 1,445,825.00 | 7.13 | 6.20 | 13.12 | 12.72 | 45.59 | 42.82 | 10.33 | 9.84 | 1.21 | 12.09 | 0.3171 | 18.87 | 9.79 | 5.65 | -14.07 | -- | 8.25 | -- |
| Beijing Tiantan Biological Products Corp | 5.23bn | 1.27bn | 43.56bn | 4.86k | 34.19 | 4.09 | -- | 8.33 | 0.6444 | 0.6444 | 2.65 | 5.38 | 0.3471 | 0.8137 | 198.92 | 1,076,946.00 | 11.47 | 11.71 | 16.75 | 16.50 | 54.23 | 49.39 | 33.05 | 27.71 | 3.31 | -- | 0.0046 | 16.67 | 21.57 | 12.06 | 25.99 | 16.85 | 29.67 | 38.97 |
| Guangzhou Baiyunshan Phrmcl Hldgs Co Ltd | 76.39bn | 3.42bn | 44.37bn | 28.05k | 13.74 | 1.30 | -- | 0.5808 | 2.11 | 2.11 | 46.99 | 22.28 | 0.9946 | 6.07 | 4.60 | 2,723,576.00 | 4.71 | 5.90 | 8.93 | 12.40 | 16.55 | 18.70 | 4.74 | 5.56 | 1.15 | -- | 0.317 | 30.02 | 6.68 | 12.32 | 2.25 | 3.34 | 27.75 | 12.05 |
| Beijing Tongrentang Co Ltd | 17.96bn | 1.63bn | 56.09bn | 16.78k | 34.45 | 4.32 | -- | 3.12 | 1.19 | 1.19 | 13.09 | 9.46 | 0.5912 | 1.08 | 11.14 | 1,070,467.00 | 7.88 | 8.20 | 15.63 | 16.17 | 44.48 | 46.59 | 13.33 | 13.33 | 1.58 | -- | 0.1765 | 30.93 | 16.19 | 4.68 | 16.92 | 8.03 | -12.01 | 13.97 |
Data as of Sep 13 2024. Currency figures normalised to Beijing Tiantan Biological Products Corp Ltd's reporting currency: Chinese Yuan Renminbi CNY
11.06%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Zhong Ou Asset Management Co., Ltdas of 30 Jun 2024 | 52.41m | 2.65% |
| China International Capital Corp. Ltd. (Invt Management)as of 30 Sep 2023 | 34.93m | 1.77% |
| CITIC Securities Co., Ltd. (Invt Port)as of 30 Jun 2024 | 30.49m | 1.54% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2024 | 26.06m | 1.32% |
| China Merchants Fund Management Co., Ltd.as of 30 Jun 2024 | 19.78m | 1.00% |
| Huatai-PineBridge Fund Management Co., Ltd.as of 30 Jun 2024 | 14.29m | 0.72% |
| Harvest Fund Management Co., Ltd.as of 30 Jun 2024 | 12.32m | 0.62% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2024 | 9.87m | 0.50% |
| China Asset Management Co., Ltd.as of 30 Jun 2024 | 9.69m | 0.49% |
| Aegon-Industrial Fund Management Co., Ltd.as of 30 Jun 2024 | 8.79m | 0.44% |
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
